Conference name:
2nd International conference on pathology
Short name:
Pathology 2019
Venue :
Paris,France| July 5-6,2019
URL:: https://bit.ly/2GS09CI
Using Surveillance, Epidemiology and End Results cancer registry, researchers assessed the clinicopathologic features, incidence and survival trends in gynecological neuroendocrine tumors (gNET). For this investigation, data were extracted regarding stage, grade, presence of extrauterine disease, receipt of adjuvant radiation, surgical intervention, incidence and overall survival. For statistical analysis, Chi-square tests, Pearson Correlation and Kaplan Meir curves were used. During the study period, 559 cases of gNET were identified.
According to results, poorly differentiated tumors accounted for 65.0% of cervical tumors, 45.3% of ovarian tumors, and 57.4% of uterine tumors. Investigators found that neuroendocrine tumors of the gynecologic tract are uncommon aggressive malignancies. These poorly differentiated tumors with a high incidence of extrauterine disease are present at an advanced stage. Despite 25 years of advances in cancer therapy, no improvement in overall survival was observed.
To know more about Pathology and its Applications do attend
International Conference on Pathology 2019 http://pathology.alliedacademies.com/
Contact
KRISTIE NOVA
Program Director | PATHOLOGY 2019
Phone: (44) 20 3769 1755
Email: pathology(at)alliedannualsummit(dot)com
No comments:
Post a Comment